Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.11
+0.44 (4.12%)
At close: Mar 9, 2026, 4:00 PM EDT
11.10
-0.01 (-0.09%)
After-hours: Mar 9, 2026, 6:05 PM EDT

Phathom Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-221.25-334.33-201.59-197.72-143.88
Upgrade
Depreciation & Amortization
0.630.80.580.620.52
Upgrade
Other Amortization
3.012.191.882.113.6
Upgrade
Stock-Based Compensation
28.7224.0545.0324.1316.81
Upgrade
Other Operating Activities
34.4855.8230.1818.891.81
Upgrade
Change in Accounts Receivable
-39.33-37.16-1.64--
Upgrade
Change in Inventory
-11.78-6.14-9.44--
Upgrade
Change in Accounts Payable
34.134.946.418.68-9.79
Upgrade
Change in Other Net Operating Assets
4.63-6.93-8.98-3.24-17.52
Upgrade
Operating Cash Flow
-166.78-266.77-137.58-146.53-148.46
Upgrade
Capital Expenditures
-0.23-0.14-1.63-1.04-0.33
Upgrade
Investing Cash Flow
-0.23-0.14-1.63-1.04-0.33
Upgrade
Long-Term Debt Issued
-59.4211.9995.4596.89
Upgrade
Total Debt Issued
-59.4211.9995.4596.89
Upgrade
Long-Term Debt Repaid
-----54.13
Upgrade
Net Debt Issued (Repaid)
-59.4211.9995.4542.76
Upgrade
Issuance of Common Stock
1.64123.37155.5924.61.94
Upgrade
Repurchase of Common Stock
-1.93----
Upgrade
Financing Cash Flow
-0.29182.77367.58120.0444.71
Upgrade
Net Cash Flow
-167.29-84.13228.37-27.53-104.08
Upgrade
Free Cash Flow
-167-266.91-139.21-147.57-148.79
Upgrade
Free Cash Flow Margin
-95.37%-483.07%-20412.61%--
Upgrade
Free Cash Flow Per Share
-2.29-4.22-2.71-3.77-4.02
Upgrade
Cash Interest Paid
21.3717.2911.137.034.07
Upgrade
Levered Free Cash Flow
-107.86-203.85-90.45-93.78-96.73
Upgrade
Unlevered Free Cash Flow
-68.3-161.04-66.1-78.83-96.08
Upgrade
Change in Working Capital
-12.38-15.3-13.645.44-27.32
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.